Temporary Facility Disruption and Mixed Sentiment Drag on Ingredion’s (INGR)Performance

Cooke & Bieler, an investment management firm, released its second-quarter investor letter for "Mid Cap Value Equity Strategy." The letter can be downloaded here. U.S. equities rallied significantly in Q2, driven by shifting geopolitical risks and strong investor appetite for high-beta stocks, particularly in the tech sector, contributing to the S&P 500® and Nasdaq's best quarterly returns in six years. Although growth outperformed value and small-cap stocks surged, the energy sector declined due to falling oil prices and developments in Iran. The Cooke & Bieler Mid Cap Value Strategy returned 8.05% in the quarter, lagging behind the Russell Midcap® Value Index's 13.4%. An underweight in Information Technology drove nearly all of the portfolio's Q2 performance shortfall as the sector surged 60% on AI capex. Despite gains in many sectors, the market's momentum is concentrated on AI-related stocks, presenting a speculative environment influenced by passive investment flows. While AI interest remains strong, the pressure for tangible financial results raises concerns about sustainability. The firm emphasizes adherence to investment principles while identifying opportunities in businesses less vulnerable to AI disruption, potentially leading to better long-term performance. You can also review the fund's top 5 holdings to see its best picks for 2026.

In its second-quarter 2026 investor letter, Cooke & Bieler Mid Cap Value Equity Strategy highlighted Ingredion Incorporated (NYSE:INGR). During the quarter, Ingredion Incorporated (NYSE:INGR), a food and beverage ingredients manufacturer, detracted from performance. On September 29, 2026, Ingredion Incorporated (NYSE:INGR) closed at $96.46, with a $6.08 billion market capitalization.Ingredion Incorporated (NYSE:INGR) posted a ~12.52% YTD pullback, trading within a 52-week range of $94.44 to $1123.49.

Cooke & Bieler Mid Cap Value Equity Strategy stated the following regarding Ingredion Incorporated (NYSE:INGR) in its Q2 2026 investor letter

"Ingredion Incorporated (NYSE:INGR), a leading global provider of ingredient solutions including starches, sweeteners, and specialty ingredients, was the third-largest detractor. Earnings were soft due to a re at the company's Argo facility, an issue that has since been resolved. Investor concern that volumes might be impacted by healthy eating trends and the adoption of GLP-1 drugs may have also weighed on shares, though we believe INGR can be part of the solution through sugar reduction and protein forti cation. In addition, the company's bid to acquire Tate & Lyle (TATE) received mixed reviews from investors."

Ingredion Incorporated (NYSE:INGR) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 34 hedge fund portfolios held Ingredion Incorporated (NYSE:INGR) at the end of the second quarter, compared to 32 in the previous quarter. While we acknowledge the potential of Ingredion Incorporated (NYSE:INGR) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

In another article, we discussed Ingredion Incorporated (NYSE:INGR) and noted that the company raised its quarterly dividend to $0.83 per share, supported by strong cash flow. In addition, please check out our hedge fund investor letters Q2 2026 page for more investor letters from hedge funds and other leading investors.

READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.

This article is originally published at Insider Monkey.